CAR T-Cell Immunotherapy Market, Global Outlook and Forecast 2023-2028

Report ID: 1372432 | Published Date: Jan 2025 | No. of Page: 101 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 CAR T-Cell Immunotherapy Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global CAR T-Cell Immunotherapy Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global CAR T-Cell Immunotherapy Overall Market Size
    2.1 Global CAR T-Cell Immunotherapy Market Size: 2021 VS 2028
    2.2 Global CAR T-Cell Immunotherapy Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top CAR T-Cell Immunotherapy Players in Global Market
    3.2 Top Global CAR T-Cell Immunotherapy Companies Ranked by Revenue
    3.3 Global CAR T-Cell Immunotherapy Revenue by Companies
    3.4 Top 3 and Top 5 CAR T-Cell Immunotherapy Companies in Global Market, by Revenue in 2021
    3.5 Global Companies CAR T-Cell Immunotherapy Product Type
    3.6 Tier 1, Tier 2 and Tier 3 CAR T-Cell Immunotherapy Players in Global Market
        3.6.1 List of Global Tier 1 CAR T-Cell Immunotherapy Companies
        3.6.2 List of Global Tier 2 and Tier 3 CAR T-Cell Immunotherapy Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global CAR T-Cell Immunotherapy Market Size Markets, 2021 & 2028
        4.1.2 Monotherapy
        4.1.3 Combination Therapy
    4.2 By Type - Global CAR T-Cell Immunotherapy Revenue & Forecasts
        4.2.1 By Type - Global CAR T-Cell Immunotherapy Revenue, 2017-2022
        4.2.2 By Type - Global CAR T-Cell Immunotherapy Revenue, 2023-2028
        4.2.3 By Type - Global CAR T-Cell Immunotherapy Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global CAR T-Cell Immunotherapy Market Size, 2021 & 2028
        5.1.2 Hematologic Malignancies
        5.1.3 Solid Malignancies
    5.2 By Application - Global CAR T-Cell Immunotherapy Revenue & Forecasts
        5.2.1 By Application - Global CAR T-Cell Immunotherapy Revenue, 2017-2022
        5.2.2 By Application - Global CAR T-Cell Immunotherapy Revenue, 2023-2028
        5.2.3 By Application - Global CAR T-Cell Immunotherapy Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global CAR T-Cell Immunotherapy Market Size, 2021 & 2028
    6.2 By Region - Global CAR T-Cell Immunotherapy Revenue & Forecasts
        6.2.1 By Region - Global CAR T-Cell Immunotherapy Revenue, 2017-2022
        6.2.2 By Region - Global CAR T-Cell Immunotherapy Revenue, 2023-2028
        6.2.3 By Region - Global CAR T-Cell Immunotherapy Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America CAR T-Cell Immunotherapy Revenue, 2017-2028
        6.3.2 US CAR T-Cell Immunotherapy Market Size, 2017-2028
        6.3.3 Canada CAR T-Cell Immunotherapy Market Size, 2017-2028
        6.3.4 Mexico CAR T-Cell Immunotherapy Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe CAR T-Cell Immunotherapy Revenue, 2017-2028
        6.4.2 Germany CAR T-Cell Immunotherapy Market Size, 2017-2028
        6.4.3 France CAR T-Cell Immunotherapy Market Size, 2017-2028
        6.4.4 U.K. CAR T-Cell Immunotherapy Market Size, 2017-2028
        6.4.5 Italy CAR T-Cell Immunotherapy Market Size, 2017-2028
        6.4.6 Russia CAR T-Cell Immunotherapy Market Size, 2017-2028
        6.4.7 Nordic Countries CAR T-Cell Immunotherapy Market Size, 2017-2028
        6.4.8 Benelux CAR T-Cell Immunotherapy Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia CAR T-Cell Immunotherapy Revenue, 2017-2028
        6.5.2 China CAR T-Cell Immunotherapy Market Size, 2017-2028
        6.5.3 Japan CAR T-Cell Immunotherapy Market Size, 2017-2028
        6.5.4 South Korea CAR T-Cell Immunotherapy Market Size, 2017-2028
        6.5.5 Southeast Asia CAR T-Cell Immunotherapy Market Size, 2017-2028
        6.5.6 India CAR T-Cell Immunotherapy Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America CAR T-Cell Immunotherapy Revenue, 2017-2028
        6.6.2 Brazil CAR T-Cell Immunotherapy Market Size, 2017-2028
        6.6.3 Argentina CAR T-Cell Immunotherapy Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa CAR T-Cell Immunotherapy Revenue, 2017-2028
        6.7.2 Turkey CAR T-Cell Immunotherapy Market Size, 2017-2028
        6.7.3 Israel CAR T-Cell Immunotherapy Market Size, 2017-2028
        6.7.4 Saudi Arabia CAR T-Cell Immunotherapy Market Size, 2017-2028
        6.7.5 UAE CAR T-Cell Immunotherapy Market Size, 2017-2028
7 Players Profiles
    7.1 AbbVie
        7.1.1 AbbVie Corporate Summary
        7.1.2 AbbVie Business Overview
        7.1.3 AbbVie CAR T-Cell Immunotherapy Major Product Offerings
        7.1.4 AbbVie CAR T-Cell Immunotherapy Revenue in Global Market (2017-2022)
        7.1.5 AbbVie Key News
    7.2 Celgene
        7.2.1 Celgene Corporate Summary
        7.2.2 Celgene Business Overview
        7.2.3 Celgene CAR T-Cell Immunotherapy Major Product Offerings
        7.2.4 Celgene CAR T-Cell Immunotherapy Revenue in Global Market (2017-2022)
        7.2.5 Celgene Key News
    7.3 Kite Pharma
        7.3.1 Kite Pharma Corporate Summary
        7.3.2 Kite Pharma Business Overview
        7.3.3 Kite Pharma CAR T-Cell Immunotherapy Major Product Offerings
        7.3.4 Kite Pharma CAR T-Cell Immunotherapy Revenue in Global Market (2017-2022)
        7.3.5 Kite Pharma Key News
    7.4 Oxford BioMedica
        7.4.1 Oxford BioMedica Corporate Summary
        7.4.2 Oxford BioMedica Business Overview
        7.4.3 Oxford BioMedica CAR T-Cell Immunotherapy Major Product Offerings
        7.4.4 Oxford BioMedica CAR T-Cell Immunotherapy Revenue in Global Market (2017-2022)
        7.4.5 Oxford BioMedica Key News
    7.5 Novartis
        7.5.1 Novartis Corporate Summary
        7.5.2 Novartis Business Overview
        7.5.3 Novartis CAR T-Cell Immunotherapy Major Product Offerings
        7.5.4 Novartis CAR T-Cell Immunotherapy Revenue in Global Market (2017-2022)
        7.5.5 Novartis Key News
    7.6 Gilead
        7.6.1 Gilead Corporate Summary
        7.6.2 Gilead Business Overview
        7.6.3 Gilead CAR T-Cell Immunotherapy Major Product Offerings
        7.6.4 Gilead CAR T-Cell Immunotherapy Revenue in Global Market (2017-2022)
        7.6.5 Gilead Key News
    7.7 Pfizer
        7.7.1 Pfizer Corporate Summary
        7.7.2 Pfizer Business Overview
        7.7.3 Pfizer CAR T-Cell Immunotherapy Major Product Offerings
        7.7.4 Pfizer CAR T-Cell Immunotherapy Revenue in Global Market (2017-2022)
        7.7.5 Pfizer Key News
    7.8 Cellectis
        7.8.1 Cellectis Corporate Summary
        7.8.2 Cellectis Business Overview
        7.8.3 Cellectis CAR T-Cell Immunotherapy Major Product Offerings
        7.8.4 Cellectis CAR T-Cell Immunotherapy Revenue in Global Market (2017-2022)
        7.8.5 Cellectis Key News
    7.9 Bellicum
        7.9.1 Bellicum Corporate Summary
        7.9.2 Bellicum Business Overview
        7.9.3 Bellicum CAR T-Cell Immunotherapy Major Product Offerings
        7.9.4 Bellicum CAR T-Cell Immunotherapy Revenue in Global Market (2017-2022)
        7.9.5 Bellicum Key News
    7.10 Mustang Bio
        7.10.1 Mustang Bio Corporate Summary
        7.10.2 Mustang Bio Business Overview
        7.10.3 Mustang Bio CAR T-Cell Immunotherapy Major Product Offerings
        7.10.4 Mustang Bio CAR T-Cell Immunotherapy Revenue in Global Market (2017-2022)
        7.10.5 Mustang Bio Key News
    7.11 CARsgen Therapeutics
        7.11.1 CARsgen Therapeutics Corporate Summary
        7.11.2 CARsgen Therapeutics Business Overview
        7.11.3 CARsgen Therapeutics CAR T-Cell Immunotherapy Major Product Offerings
        7.11.4 CARsgen Therapeutics CAR T-Cell Immunotherapy Revenue in Global Market (2017-2022)
        7.11.5 CARsgen Therapeutics Key News
    7.12 Xyphos
        7.12.1 Xyphos Corporate Summary
        7.12.2 Xyphos Business Overview
        7.12.3 Xyphos CAR T-Cell Immunotherapy Major Product Offerings
        7.12.4 Xyphos CAR T-Cell Immunotherapy Revenue in Global Market (2017-2022)
        7.12.5 Xyphos Key News
    7.13 Minerva Biotechnologies
        7.13.1 Minerva Biotechnologies Corporate Summary
        7.13.2 Minerva Biotechnologies Business Overview
        7.13.3 Minerva Biotechnologies CAR T-Cell Immunotherapy Major Product Offerings
        7.13.4 Minerva Biotechnologies CAR T-Cell Immunotherapy Revenue in Global Market (2017-2022)
        7.13.5 Minerva Biotechnologies Key News
    7.14 Adaptimmune
        7.14.1 Adaptimmune Corporate Summary
        7.14.2 Adaptimmune Business Overview
        7.14.3 Adaptimmune CAR T-Cell Immunotherapy Major Product Offerings
        7.14.4 Adaptimmune CAR T-Cell Immunotherapy Revenue in Global Market (2017-2022)
        7.14.5 Adaptimmune Key News
    7.15 Ziopharm Oncology
        7.15.1 Ziopharm Oncology Corporate Summary
        7.15.2 Ziopharm Oncology Business Overview
        7.15.3 Ziopharm Oncology CAR T-Cell Immunotherapy Major Product Offerings
        7.15.4 Ziopharm Oncology CAR T-Cell Immunotherapy Revenue in Global Market (2017-2022)
        7.15.5 Ziopharm Oncology Key News
    7.16 Aurora Biopharma
        7.16.1 Aurora Biopharma Corporate Summary
        7.16.2 Aurora Biopharma Business Overview
        7.16.3 Aurora Biopharma CAR T-Cell Immunotherapy Major Product Offerings
        7.16.4 Aurora Biopharma CAR T-Cell Immunotherapy Revenue in Global Market (2017-2022)
        7.16.5 Aurora Biopharma Key News
    7.17 Creative Biolabs
        7.17.1 Creative Biolabs Corporate Summary
        7.17.2 Creative Biolabs Business Overview
        7.17.3 Creative Biolabs CAR T-Cell Immunotherapy Major Product Offerings
        7.17.4 Creative Biolabs CAR T-Cell Immunotherapy Revenue in Global Market (2017-2022)
        7.17.5 Creative Biolabs Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. CAR T-Cell Immunotherapy Market Opportunities & Trends in Global Market
    Table 2. CAR T-Cell Immunotherapy Market Drivers in Global Market
    Table 3. CAR T-Cell Immunotherapy Market Restraints in Global Market
    Table 4. Key Players of CAR T-Cell Immunotherapy in Global Market
    Table 5. Top CAR T-Cell Immunotherapy Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global CAR T-Cell Immunotherapy Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global CAR T-Cell Immunotherapy Revenue Share by Companies, 2017-2022
    Table 8. Global Companies CAR T-Cell Immunotherapy Product Type
    Table 9. List of Global Tier 1 CAR T-Cell Immunotherapy Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 CAR T-Cell Immunotherapy Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - CAR T-Cell Immunotherapy Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - CAR T-Cell Immunotherapy Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - CAR T-Cell Immunotherapy Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - CAR T-Cell Immunotherapy Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global CAR T-Cell Immunotherapy Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global CAR T-Cell Immunotherapy Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2023-2028
    Table 30. AbbVie Corporate Summary
    Table 31. AbbVie CAR T-Cell Immunotherapy Product Offerings
    Table 32. AbbVie CAR T-Cell Immunotherapy Revenue (US$, Mn), (2017-2022)
    Table 33. Celgene Corporate Summary
    Table 34. Celgene CAR T-Cell Immunotherapy Product Offerings
    Table 35. Celgene CAR T-Cell Immunotherapy Revenue (US$, Mn), (2017-2022)
    Table 36. Kite Pharma Corporate Summary
    Table 37. Kite Pharma CAR T-Cell Immunotherapy Product Offerings
    Table 38. Kite Pharma CAR T-Cell Immunotherapy Revenue (US$, Mn), (2017-2022)
    Table 39. Oxford BioMedica Corporate Summary
    Table 40. Oxford BioMedica CAR T-Cell Immunotherapy Product Offerings
    Table 41. Oxford BioMedica CAR T-Cell Immunotherapy Revenue (US$, Mn), (2017-2022)
    Table 42. Novartis Corporate Summary
    Table 43. Novartis CAR T-Cell Immunotherapy Product Offerings
    Table 44. Novartis CAR T-Cell Immunotherapy Revenue (US$, Mn), (2017-2022)
    Table 45. Gilead Corporate Summary
    Table 46. Gilead CAR T-Cell Immunotherapy Product Offerings
    Table 47. Gilead CAR T-Cell Immunotherapy Revenue (US$, Mn), (2017-2022)
    Table 48. Pfizer Corporate Summary
    Table 49. Pfizer CAR T-Cell Immunotherapy Product Offerings
    Table 50. Pfizer CAR T-Cell Immunotherapy Revenue (US$, Mn), (2017-2022)
    Table 51. Cellectis Corporate Summary
    Table 52. Cellectis CAR T-Cell Immunotherapy Product Offerings
    Table 53. Cellectis CAR T-Cell Immunotherapy Revenue (US$, Mn), (2017-2022)
    Table 54. Bellicum Corporate Summary
    Table 55. Bellicum CAR T-Cell Immunotherapy Product Offerings
    Table 56. Bellicum CAR T-Cell Immunotherapy Revenue (US$, Mn), (2017-2022)
    Table 57. Mustang Bio Corporate Summary
    Table 58. Mustang Bio CAR T-Cell Immunotherapy Product Offerings
    Table 59. Mustang Bio CAR T-Cell Immunotherapy Revenue (US$, Mn), (2017-2022)
    Table 60. CARsgen Therapeutics Corporate Summary
    Table 61. CARsgen Therapeutics CAR T-Cell Immunotherapy Product Offerings
    Table 62. CARsgen Therapeutics CAR T-Cell Immunotherapy Revenue (US$, Mn), (2017-2022)
    Table 63. Xyphos Corporate Summary
    Table 64. Xyphos CAR T-Cell Immunotherapy Product Offerings
    Table 65. Xyphos CAR T-Cell Immunotherapy Revenue (US$, Mn), (2017-2022)
    Table 66. Minerva Biotechnologies Corporate Summary
    Table 67. Minerva Biotechnologies CAR T-Cell Immunotherapy Product Offerings
    Table 68. Minerva Biotechnologies CAR T-Cell Immunotherapy Revenue (US$, Mn), (2017-2022)
    Table 69. Adaptimmune Corporate Summary
    Table 70. Adaptimmune CAR T-Cell Immunotherapy Product Offerings
    Table 71. Adaptimmune CAR T-Cell Immunotherapy Revenue (US$, Mn), (2017-2022)
    Table 72. Ziopharm Oncology Corporate Summary
    Table 73. Ziopharm Oncology CAR T-Cell Immunotherapy Product Offerings
    Table 74. Ziopharm Oncology CAR T-Cell Immunotherapy Revenue (US$, Mn), (2017-2022)
    Table 75. Aurora Biopharma Corporate Summary
    Table 76. Aurora Biopharma CAR T-Cell Immunotherapy Product Offerings
    Table 77. Aurora Biopharma CAR T-Cell Immunotherapy Revenue (US$, Mn), (2017-2022)
    Table 78. Creative Biolabs Corporate Summary
    Table 79. Creative Biolabs CAR T-Cell Immunotherapy Product Offerings
    Table 80. Creative Biolabs CAR T-Cell Immunotherapy Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. CAR T-Cell Immunotherapy Segment by Type in 2021
    Figure 2. CAR T-Cell Immunotherapy Segment by Application in 2021
    Figure 3. Global CAR T-Cell Immunotherapy Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global CAR T-Cell Immunotherapy Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global CAR T-Cell Immunotherapy Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by CAR T-Cell Immunotherapy Revenue in 2021
    Figure 8. By Type - Global CAR T-Cell Immunotherapy Revenue Market Share, 2017-2028
    Figure 9. By Application - Global CAR T-Cell Immunotherapy Revenue Market Share, 2017-2028
    Figure 10. By Region - Global CAR T-Cell Immunotherapy Revenue Market Share, 2017-2028
    Figure 11. By Country - North America CAR T-Cell Immunotherapy Revenue Market Share, 2017-2028
    Figure 12. US CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe CAR T-Cell Immunotherapy Revenue Market Share, 2017-2028
    Figure 16. Germany CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 17. France CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia CAR T-Cell Immunotherapy Revenue Market Share, 2017-2028
    Figure 24. China CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 28. India CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America CAR T-Cell Immunotherapy Revenue Market Share, 2017-2028
    Figure 30. Brazil CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa CAR T-Cell Immunotherapy Revenue Market Share, 2017-2028
    Figure 33. Turkey CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
    Figure 37. AbbVie CAR T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Celgene CAR T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Kite Pharma CAR T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Oxford BioMedica CAR T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Novartis CAR T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Gilead CAR T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Pfizer CAR T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Cellectis CAR T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Bellicum CAR T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Mustang Bio CAR T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. CARsgen Therapeutics CAR T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. Xyphos CAR T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 49. Minerva Biotechnologies CAR T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 50. Adaptimmune CAR T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 51. Ziopharm Oncology CAR T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 52. Aurora Biopharma CAR T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 53. Creative Biolabs CAR T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
101
Frequently Asked Questions
CAR T-Cell Immunotherapy Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
CAR T-Cell Immunotherapy Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
CAR T-Cell Immunotherapy Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Banana Pulp Market

The Banana Pulp industry concentration is unbalance; there are more than one hundreds manufacture ... Read More